[Elsevier] A pharmacovigilance study of FDA adverse events for sugammadex |
|
This post will be closed automatically in 2026-07-09 22:59
Reward10points
|
20
Carbon dot nanozymes: Mechanisms of ROS modulation and biomedical applications
20
Heteroatom co-doping (N, NS, NB) on carbon dots and their antibacterial and antioxidant properties
20
Genistein carbon dots exhibit antioxidant and anti-inflammatory effects in vitro
20
Fluorine and nitrogen co-doped carbon dots (F, N-CDs) for enhanced luminol chemiluminescence and sensitive detection of levetiracetam
10
Optimized last quantum barrier design for enhanced performance of Ultraviolet-C (UV-C) AlGaN nanowire light-emitting diodes
